Moreover, patients presenting with EZH2 overexpression showed a significantly lower survival rate compared to those having low EZH2 expression.111 KMT1C (G9a) is upregulated in breast cancer, colon cancer and gastric cancer,112–114 which is indicative of poor prognosis of various tumors. This evidence concerns the gene EZH2 and breast cancer.